Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico

Journal of Clinical Microbiology

Volumn 43, Issue 8, 2005, Pages 4159-4162

  Sánchez Vargas, Luis Octavio ^a,b   Ortiz López, Natalia Guadalupe ^a   Villar, María ^a   Moragues, María Dolores ^a   Aguirre, José Manuel ^a   Cashat Cruz, Miguel ^c   Lopez Ribot, Jose Luis ^d   Gaitán Cepeda, Luis Alberto ^b   Quindós, Guillermo ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CHILD; CONTROLLED STUDY; FUNGAL COLONIZATION; FUNGUS ISOLATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEXICO; PRIORITY JOURNAL; T LYMPHOCYTE; THRUSH; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDA; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MIDDLE AGED; MOUTH;

CANDIDA; CANDIDA ALBICANS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 23744491255     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.8.4159-4162.2005     Document Type: Article

References (27)

1. Barchiesi, F., M. Maracci, B. Radi, D. Arzeni, J. Baldassarri, A. Giacometti, and G. Scalise. 2002. Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. J. Antimicrob. Chemother. 50:999-1002.
2. Barchiesi, F., V. Morbiducci, F. Ancarani, and G. Scalise. 1993. Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients. Eur. J. Epidemiol. 9:455-456.
3. Bikandi, J., R. San Millán, M. D. Moragues, G. Cebas, D. C. Coleman, G. Quindós, and J. Pontón. 1998. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J. Clin. Microbiol. 36:2428-2433.
4. Blignaut, E., S. Messer, R. J. Hollis, and M. A. Pfaller. 2002. Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals. Diagn. Microbiol. Infect. Dis. 44:169-174.
5. Ceballos-Salobrena, A., L. Gaitán-Cepeda, L. Ceballos- García, and L. P. Samaranayake. 2004. The effect of antiretroviral therapy on the prevalence of HIV-associated oral candidiasis in a Spanish cohort. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 97:345-350.
6. Ceballos-Salobrena, A., L. A. Gaitán-Cepeda, F. Orihuela-Can̄ada, D. Barrionuevo Olea, L. Ceballos-Garcia, and G. Quindos. 1999. Resistencia in vitro a los amifúngicos en Candida albicans de pacientes infectados por el VIH con y sin candidiasis oral. Rev. Iberoam. Micol. 16:194-197.
7. Ceballos-Salobreña, A., G. Quindós-Andrés, and L. Ceballos-García. 2000. The influence of different risk behaviors in the appearance of oral candidiasis in AIDS patients. Med. Oral 5:71-80.
8. CONASIDA. 2003. Panorama epidemiológico del VIH/SIDA e ITS en México, Consejo Nacional para la Prevención y control del VIH/SIDA, Secretaría de Salud, México. Dirección General de Epidemiología, Mexico City, Mexico. [Online.] http://www.salud.gob.mx/ conasida.
9. Davey, K. G., A. D. Holmes, E. M. Johnson, A. Szekely, and D. W. Warnock. 1998. Comparative evaluation of Fungitest and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J. Clin. Microbiol. 36:926-930.
10. Diekema, D. J., M. A. Pfaller, S. A. Messer, A. Houston, R. J. Hollis, G. V. Doern, R. N. Jones, et al. 1999. In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY antimicrobial surveillance program in North America and Latin America. Antimicrob. Agents Chemother. 43:2236-2239.
11. Diz-Dios, P., A. Ocampo, I. Otero, I. Iglesias, and C. Martínez. 2001. Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients. J. Infect. Dis. 183:355-356.
12. Gaitan-Cepeda, L., M. Cashat-Cruz, J. J. Morales-Aguirre, L. Sanchez-Vargas, S. Aquino-Garcia, R. Fragoso-Rios, V. Cuairan-Ruidiaz, C. Avila-Figueroa, J. Morales, and C. A. Figueroa. 2002. Prevalence of oral lesions in Mexican children with perinatally acquired HIV: association with immunologic status, viral load, and gender. AIDS Patient Care STDS 16:151-156.
13. Gottfredsson, M., G. M. Cox, O. S. Indridason, G. M. D. De Almeida, A. E. Heald, and J. R. Perfect. 1999. Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization. J. Infect. Dis. 180:534-537.
14. Martins, M. D., M. Lozano-Chiu, and J. H. Rex. 1997. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 25:843-846.
15. Martins, M. D., M. Lozano-Chiu, and J. H. Rex. 1998. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 27:1291-1294.
16. Odds, F. C. 1988. Candida and candidiasis, 2nd ed. Baillière Tindall, London, United Kingdom.
17. Pfaller, M. A., R. N. Jones, G. V, Doern, H. S. Sader, R. J. Hollis, S. A. Messer, et al. 1998. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY program. J. Clin. Microbiol. 36:1886-1889.
18. Quindós, G., M. T. Ruesga, E. Martín-Mazuelos, R, Salesa, R. Alonso-Vargas, A. J. Carrillo-Muñoz, S. Brena, R. San-Millán, and J. Pontón. 2004. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev. Iberoam. Micol. 21:63-69.
19. Ramirez-Amador, V., L. Esquivel-Pedraza, J. Sierra-Madero, G. Anaya-Saavedra, I. Gonzalez-Ramirez, and S. Ponce-de-Leon. 2003. The changing clinical spectrum of human immunodeficiency virus-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine 82:39-50.
20. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
21. Vargas, K. G., and S. Joly. 2002. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J. Clin. Microbiol. 40:341-350.
22. Williams, D. W., and M. A. O. Lewis. 2000. Isolation and identification of Candida from the oral cavity. Oral Dis. 6:3-11.
23. Willinger, B., P. Apfalter, A. M. Hirschl, A. Makristathis, M. Rotter, and M. Seibold. 2000. Susceptibility testing of Candida species: comparison of NC-CLS microdilution method with Fungitest®. Diagn. Microbiol. Infect. Dis. 38:11-15.
24. Willinger, B., E. Engelmann, H. Hofmann, S. Metzger, P. Apfalter, A. M. Hirschl, A. Makristathis, M. Rotter, B. Raddatz, and M. Seibold. 2002. Multicenter comparison of Fungitest for susceptibility testing of Candida species. Diagn. Microbiol. Infect. Dis. 44:253-257.
25. Witthuhn, F., D. Toubas, I. Béguinot, D. Aubert, C. Rouger, G. Remy, and J. M. Pinon. 1999. Evaluation of the Fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility. J. Clin. Microbiol. 3:864-866.
26. Wroblewska, M. M., E. Swoboda-Kopec, A. Rokosz, E. Krawczyk, H. Marchel, and M. Luczak. 2002. Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles. Int. J. Antimicrob. Agents 20:472-475.
27. Xu, J., and T. G. Mitchell. 2003. Geographical differences in human oral yeast flora. Clin. Infect. Dis. 36:221-224.